1. Home
  2. TARS vs MGRC Comparison

TARS vs MGRC Comparison

Compare TARS & MGRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$65.11

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Logo McGrath RentCorp

MGRC

McGrath RentCorp

HOLD

Current Price

$113.77

Market Cap

2.8B

ML Signal

HOLD

Company Overview

Basic Information
Metric
TARS
MGRC
Founded
2016
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Diversified Commercial Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.8B
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
TARS
MGRC
Price
$65.11
$113.77
Analyst Decision
Buy
Buy
Analyst Count
6
2
Target Price
$89.00
$141.50
AVG Volume (30 Days)
595.9K
263.6K
Earning Date
05-06-2026
04-29-2026
Dividend Yield
N/A
1.67%
EPS Growth
48.21
N/A
EPS
N/A
1.10
Revenue
$451,360,000.00
$944,235,000.00
Revenue This Year
$56.43
$4.69
Revenue Next Year
$30.19
$4.81
P/E Ratio
N/A
$103.40
Revenue Growth
146.71
3.65
52 Week Low
$38.51
$94.99
52 Week High
$85.25
$128.41

Technical Indicators

Market Signals
Indicator
TARS
MGRC
Relative Strength Index (RSI) 51.22 51.39
Support Level $61.24 $104.24
Resistance Level $67.24 $118.78
Average True Range (ATR) 3.59 3.25
MACD 0.09 -0.19
Stochastic Oscillator 81.30 57.29

Price Performance

Historical Comparison
TARS
MGRC

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

About MGRC McGrath RentCorp

McGrath RentCorp is a diversified business-to-business rental company with three rental divisions: relocatable modular buildings, portable storage containers, and electronic test equipment. It comprises four reportable business segments, namely the Modular Building segment (Mobile Modular), which generates maximum revenue; the Portable Storage segment (Portable Storage); the Electronic Test Equipment segment (TRS-RenTelco); and its classroom manufacturing business (Enviroplex), which sells modular buildings used as classrooms in California. The company generates its revenues mainly from the rental of its equipment under operating leases, with sales of equipment occurring in the normal course of business.

Share on Social Networks: